Physician profile
Ralph E Williams
NPI 1396942454
$4,617.54
in general payments reported to CMS, 2019-2025
28 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $204 · 2021: $959 · 2022: $670 · 2023: $235 · 2024: $615 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $750.62 | 2019-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Astrazeneca Pharmaceuticals Lp | $715.95 | 2019-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $569.12 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $486.64 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $276.00 | 2023-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Lilly USA, LLC | $201.64 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $181.85 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.48 | 2019-2022 | |
| Inari Medical, INC. | $167.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biohaven Pharmaceuticals, INC. | $146.00 | 2020-2021 | |
| Amarin Pharma, INC. | $144.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $130.23 | 2021 | |
| Pfizer INC. | $95.39 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $82.56 | 2021-2023 | |
| Amgen INC. | $81.15 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $79.80 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $58.21 | 2020-2022 | |
| Exact Sciences Corporation | $55.72 | 2024-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $36.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.73 | 2021 | |
| Biogen, INC. | $23.51 | 2022 | |
| Organon LLC | $22.41 | 2023 | Nexplanon |
| Otsuka America Pharmaceutical, INC. | $21.14 | 2022 | |
| Phadia US INC. | $18.25 | 2025 | Immunocap |
| Sunovion Pharmaceuticals INC. | $17.61 | 2019 | |
| Becton, Dickinson and Company | $15.59 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.56 | 2025 | Zoryve |
| Intuitive Surgical, INC. | $14.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.